Anti-Phosphohistone H3-Positive Mitoses Are Linked to Pathological Response in Neoadjuvantly Treated Breast Cancer

Martin Sillem, Sylvia Timme, Peter Bronsert, Lioudmila Bogatyreva, Dieter Hauschke, Axel zur Hausen, Martin Werner, Elmar Stickeler*

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)244-250
Number of pages7
JournalBreast Care
Volume12
Issue number4
DOIs
Publication statusPublished - 2017

Keywords

  • Breast cancer
  • Mitotic count
  • PHH3
  • Neoadjuvant therapy
  • SURGICAL ADJUVANT BREAST
  • PREOPERATIVE CHEMOTHERAPY
  • PROGNOSTIC VALUE
  • PROLIFERATION
  • CARCINOMA
  • PHOSPHORYLATION
  • RECOMMENDATIONS
  • CONDENSATION
  • EXPRESSION
  • CONSENSUS

Cite this

Sillem, M., Timme, S., Bronsert, P., Bogatyreva, L., Hauschke, D., zur Hausen, A., Werner, M., & Stickeler, E. (2017). Anti-Phosphohistone H3-Positive Mitoses Are Linked to Pathological Response in Neoadjuvantly Treated Breast Cancer. Breast Care, 12(4), 244-250. https://doi.org/10.1159/000463377